CoChat
Sign Up
Cited by 460

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B., Greve, D., Hevelone, N., Hersch, S. M.·2008·Brain
DOI 10.1093/brain/awn025
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awn025

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994; 44: 823-8.
  2. Banich MT, Milham MP, Atchley R, Cohen NJ, Webb A, Wszalek T, et al. fMri studies of Stroop tasks reveal unique roles of anterior and posterior brain systems in attentional selection. J Cogn Neurosci 2000; 12: 988-1000.
  3. Billingsley RL, Simos PG, Castillo EM, Sarkari S, Breier JI, Pataraia E, et al. Spatio-temporal cortical dynamics of phonemic and semantic fluency. J Clin Exp Neuropsychol 2004; 26: 1031-43.
  4. Braak H, Braak E. Allocortical involvement in Huntington's disease. Neuropathol Appl Neurobiol 1992; 18: 539-47.
  5. Brandt J, Shpritz B, Munro CA, Marsh L, Rosenblatt A. Differential impairment of spatial location memory in Huntington's disease. J Neurol Neurosurg Psychiatry 2005; 76: 1516-9.
  6. Browne SE, Beal MF. Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 2006; 8: 2061-73.
  7. Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006; 129: 564-83.
  8. Cha J-HJ. Transcriptional signatures in Huntingtons disease. Progress in Neurobiology 2007; in press.
  9. Connick JH, Carla V, Moroni F, Stone TW. Increase in kynurenic acid in Huntington's disease motor cortex. J Neurochem 1989; 52: 985-7.
  10. Costafreda SG, Fu CH, Lee L, Everitt B, Brammer MJ, David AS. A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp 2006; 27: 799-810.
  11. de la Monte SM, Vonsattel JP, Richardson EP, Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988; 47: 516-25.
  12. Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp Brain Res 1991; 84: 393-402.
  13. DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 2004; 33: 517-33.
  14. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, et al. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562-75.
  15. Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, et al. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med 2001; 42: 1591-5.
  16. Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001; 20: 70-80.
  17. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-8.
  18. Georgiou-Karistianis N, Sritharan A, Farrow M, Cunnington R, Stout J, Bradshaw J, et al. Increased cortical recruitment in Huntington's disease using a Simon task. Neuropsychologia 2007; 45: 1791-800.
  19. Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ. A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 2005; 37: 526-31.
  20. Group HS. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996; 11: 136-42.
  21. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 1999; 19: 2522-34.
  22. Halari R, Sharma T, Hines M, Andrew C, Simmons A, Kumari V. Comparable fMRI activity with differential behavioural performance on mental rotation and overt verbal fluency tasks in healthy men and women. Exp Brain Res 2006; 169: 1-14.
  23. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 1998; 154: 663-72.
  24. Halsband U, Matsuzaka Y, Tanji J. Neuronal activity in the primate supplementary, pre-supplementary and premotor cortex during exter- nally and internally instructed sequential movements. Neurosci Res 1994; 20: 149-55.
  25. Hamilton JM, Haaland KY, Adair JC, Brandt J. Ideomotor limb apraxia in Huntington's disease: implications for corticostriate involvement. Neuropsychologia 2003; 41: 614-21.
  26. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001; 124: 558-70.
  27. Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991; 133: 257-61.
  28. Heilman KM, Rothi LG, Mack L, Feinberg T, Watson RT. Apraxia after a superior parietal lesion. Cortex 1986; 22: 141-50.
  29. Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, et al. Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol (Berl) 1994; 88: 320-33.
  30. Hersch S, Rosas HD, Ferrante RJ. Neuropathology and pathophysiology of Huntington's disease. New York: McGraw-Hill; 2004.
  31. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 2006; 15: 965-77.
  32. Jackson M, Gentleman S, Lennox G, Ward L, Gray T, Randall K, et al. The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol 1995; 21: 18-26.
  33. Jenkins BG, Andreassen OA, Dedeoglu A, Leavitt B, Hayden M, Borchelt D, et al. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. J Neurochem 2005; 95: 553-62.
  34. Kassubek J, Bernhard Landwehrmeyer G, Ecker D, Juengling FD, Muche R, Schuller S, et al. Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport 2004; 15: 363-5.
  35. Lange H, Thorner G, Hopf A, Schroder KF. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 1976; 28: 401-25.
  36. Leung HC, Skudlarski P, Gatenby JC, Peterson BS, Gore JC. An event- related functional MRI study of the stroop color word interference task. Cereb Cortex 2000; 10: 552-60.
  37. Macdonald V, Halliday G. Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 2002; 10: 378-86.
  38. Mann DM, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (Berl) 1993a; 85: 553-9.
  39. Mann DMA, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (Berl) 1993b; 85: 553-9.
  40. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000; 54: 452-8.
  41. Nardone R, Lochner P, Marth R, Ausserer H, Bratti A, Tezzon F. Abnormal intracortical facilitation in early-stage Huntington's disease. Clin Neurophysiol 2007; 118: 1149-54.
  42. Parthasarathy HB, Graybiel AM. Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J Neurosci 1997; 17: 2477-91.
  43. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-61.
  44. Raichle ME. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci USA 1998; 95: 765-72.
  45. Reading SA, Dziorny AC, Peroutka LA, Schreiber M, Gourley LM, Yallapragada V, et al. Functional brain changes in presymptomatic Huntington's disease. Ann Neurol 2004; 55: 879-83.
  46. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005; 65: 745-7.
  47. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relation- ship to clinical measures. Mov Disord 2006; 21: 1317-25.
  48. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RS, Busa E, et al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004; 14: 721-30.
  49. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997; 42: 604-12.
  50. Selemon LD, Rajkowska G, Goldman-Rakic PS. Evidence for progression in frontal cortical pathology in late-stage Huntington's disease. J Comp Neurol 2004; 468: 190-204.
  51. Sieradzan KA, Mann DM. The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol 2001; 27: 1-21.
  52. Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, et al. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. J Neurosci 2007; 27: 12908-15.
  53. Storey E, Kowall NW, Finn SF, Mazurek MF, Beal MF. The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex. Ann Neurol 1992; 32: 526-34.
  54. Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815-28.
  55. Thiruvady DR, Georgiou-Karistianis N, Egan GF, Ray S, Sritharan A, Farrow M, et al. Functional connectivity of the prefrontal cortex in Huntington's disease. J Neurol Neurosurg Psychiatry 2007; 78: 127-33.
  56. van Dellen A, Deacon R, York D, Blakemore C, Hannan AJ. Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Res Bull 2001; 56: 313-8.
  57. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP, Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-77.

Cited by

Sorted by citations

See all 460

Metadata

Authors
Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B., Greve, D., Hevelone, N., & Hersch, S. M.
Venue
Brain
Publisher
Oxford University Press (OUP)
Published
2008-02-26
Volume
131
Issue
4
Pages
1057-1068
ISSN
  • 0006-8950
  • 1460-2156
DOI
10.1093/brain/awn025
Cited by
460
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review